TY - JOUR T1 - Value of adding behavioral-cognitive therapy to standard treatment in smoking cessation programe:results of Smoking Cessation Center Oradea on 7 years JF - European Respiratory Journal JO - Eur Respir J VL - 44 IS - Suppl 58 SP - P4161 AU - Lavinia Davidescu AU - Raluca Jurca AU - Ruxandra Ulmeanu Y1 - 2014/09/01 UR - http://erj.ersjournals.com/content/44/Suppl_58/P4161.abstract N2 - BACKGROUNDIn smoking cessation interventional diagrams do not presents exceptional results, but the association of behavioral-cognitive therapy to drug treatment (bupropion , varenicline, nicotine substitutes or combinations) significantly improves outcomes.OBJECTIVESTo assess the value of adding behavioral-cognitive therapy to standard treatment in smoking cessation program:results of Smoking cessation Center Oradea on 7 years, between 2007-2013.METHODWe analyzed 970 smokers patients , with age between 18-70 years, who were treated for smoking cessation during 2007-2013 in our Smoking Cessation Center Oradea. Of these, 388 patients (40%) received drug treatment with bupropion, varenicline, nicotine replacements or combinations, and 562 patients (58%) received drug treatment and behavioral-cognitive therapy.Treatment duration was 2 months for patients receiving therapy with bupropion / nicotine substitutes, and 3 months for those who received varenicline therapy, with or without behavioral-cognitive therapy.2% of patients did not receive drug treatment, presenting chronic diseases representing contraindications for drug therapy.The 2 groups were assessed at the end of therapy, at 3 months follow-up, and at 1 year follow-up.RESULTSSuccess rate at 3 months follow-up was 29.8% for group I and 40% for group II,which associated behavioral-cognitive therapy to drug therapy. At 1 year follow-up, group I had a success rate of 26% and group II-38, 9%.CONCLUSIONAssociated behavioral-cognitive therapy to standard drug therapy significantly increases the success rate of smoking cessation program. ER -